Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
09 August 2023Website:
http://neuraxis.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 26 Jun 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
NRXS Latest News
CARMEL, Ind., June 07, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced a submission to the FDA for expansion of its IB-Stim label. The new submission is significant as it would allow access to a larger patient population beyond 11-18 years of age and allow for marketing of 4 devices per prescription.
NeurAxis, Inc. (NYSE:NRXS ) Q1 2024 Earnings Conference Call May 22, 2024 9:00 AM ET Company Participants Ben Shamsian - Investor Relations Brian Carrico - Chief Executive Officer Tim Henrichs - Chief Financial Officer Operator Good day, and thank you for standing by. Welcome to NeurAxis Reports First Quarter 2024 Financial Results.
CARMEL, Ind., May 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the first quarter 2024 for the period ended March 31, 2024.
NeurAxis, a medical technology company with an FDA-approved therapy to treat abdominal pain associated with IBS in adolescents aged 11 to 18 years old, tweaked the terms of its initial public offering on Friday. In a filing with the Securities and Exchange Commission, the company said it now plans to offer 1.7 million shares priced at $6 each, while selling shareholders will offer 2.8 million shares.
What type of business is NeurAxis?
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
What sector is NeurAxis in?
NeurAxis is in the Healthcare sector
What industry is NeurAxis in?
NeurAxis is in the Biotechnology industry
What country is NeurAxis from?
NeurAxis is headquartered in United States
When did NeurAxis go public?
NeurAxis initial public offering (IPO) was on 09 August 2023
What is NeurAxis website?
https://neuraxis.com
Is NeurAxis in the S&P 500?
No, NeurAxis is not included in the S&P 500 index
Is NeurAxis in the NASDAQ 100?
No, NeurAxis is not included in the NASDAQ 100 index
Is NeurAxis in the Dow Jones?
No, NeurAxis is not included in the Dow Jones index
When does NeurAxis report earnings?
Next earnings report date is not announced yet